新文章：伊维菌素、美苯达唑、羟氯喹患者证言 - 波兰一名68岁女性多发性骨髓瘤患者报告6个月后情况

伊维菌素革命席卷波兰！🇵🇱

故事：波兰一名68岁女性患者患有多发性骨髓瘤，并伴有T11和L3两个溶骨性病灶。

12月，她开始服用：伊维菌素 1mg/kg/天芬苯达唑 1500mg/天

1月，她添加：羟氯喹 400mg/天

2月，她添加：美苯达唑 1500mg/天

6个月后的结果：

Lambda游离轻链 44.92（正常值 5.7-26.3）降至正常

“她最近的血清蛋白电泳显示电泳图谱上无明显单克隆峰。

“她目前感觉非常好”

在血液系统癌症中使用再利用药物现正被探索，因为伊维菌素的使用最早于2020年在儿童白血病中发表。

羟氯喹在癌症中的使用是一个新颖的想法，最近研究激增，PubMed显示超过1000个结果（已发表研究）...

一些医生对伊维菌素的非理性精神病态仇恨完全是错位的。在癌症中再利用药物的前沿应用远远超出了伊维菌素！😃

我在全球最大的“知情尝试”研究项目中，使用伊维菌素、美苯达唑和芬苯达唑帮助了超过9000名癌症患者。

NEW ARTICLE: IVERMECTIN, MEBENDAZOLE, HYDROXYCHLOROQUINE Testimonial - 68 year old woman in Poland with Multiple Myeloma reports after 6 months

Ivermectin Revolution is sweeping into POLAND! 🇵🇱

STORY:68 year old woman in Poland with Multiple Myeloma and two osteolytic lesions in T11 and L3.

In December she started:Ivermectin 1mg/kg/dayFenbendazole 1500mg/day

In January she added:Hydroxychloroquine 400mg/day

In February she added:Mebendazole 1500mg/day

Results after 6 months:

Lambda free light chains 44.92 (N 5.7-26.3) dropped to Normal

"Her latest serum protein electrophoresis shows no obvious monoclonal spike on electrophoresis tracing.

"She is feeling very well at the moment"

The use of repurposed drugs in hematological cancers is now being explored, as the use of Ivermectin was first published in Leukemia in children in 2020.

Hydroxychloroquine use in Cancer is a novel idea with an explosion of recent research and Pubmed showing over 1000 results (published studies)...

The irrational psychotic hate of Ivermectin by some doctors is completely misplaced. The cutting edge use of repurposed drugs in Cancer goes way beyond Ivermectin! 😃

I have helped over 9000 Cancer patients with Ivermectin, Mebendazole and Fenbendazole in the largest "Right to Try" Research project in the world.